Corporate Board Profile
Tech Score: 29/100
6 mention(s) identify TIMOTHY J. TRICHE, MD as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| LTC PROPERTIES INC | 2016-04-26 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private biotechnology company, Lifecode, Inc. (f/k/a Silicon Valley Biosystems), a private biotechnology company, and Sanguine BioSciences, a private biomedical research company. | Dr. Triche has a background in pathology and laboratory medicine and serves on the boards of several private biotechnology and nanotechnology companies, indicating a technical and scientific background that likely includes software-related skills. |
| LTC PROPERTIES INC | 2018-04-24 | Dr. Triche is the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles and serves on the Board of Directors of several private biotechnology and nanotechnology companies, including MedGenome, Inc. (f/k/a Silicon Valley Biosystems and Lifecode, Inc.), which suggests software-related technical expertise. | Dr. Triche has a background in personalized medicine and serves on boards of biotechnology and nanotechnology companies, indicating familiarity with technical and scientific fields that likely include software-related skills. |
| LTC PROPERTIES INC | 2020-04-21 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010 and serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private biotechnology company, MedGenome, Inc., a private biotechnology company, and Sanguine BioSciences, a private biomedical research company. | Dr. Triche has a background in personalized medicine and serves on boards of biotechnology and nanotechnology companies, indicating technical expertise likely including programming or related skills. |
| LTC PROPERTIES INC | 2021-04-20 | Dr. Triche is Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles and serves on boards of private biotechnology and nanotechnology companies. | Dr. Triche has a background in personalized medicine and serves on boards of biotechnology and nanotechnology companies, indicating technical expertise likely including programming or related skills. |
| LTC PROPERTIES INC | 2022-04-19 | Dr. Triche is Director of the Center for Personalized Medicine and serves on boards of private biotechnology and nanotechnology companies, indicating a technical background relevant to software and programming. | He has a background in medicine and biomedical research and serves on boards of biotechnology and nanotechnology companies, indicating technical expertise likely including programming or related skills. |
| LTC PROPERTIES INC | 2023-04-18 | Dr. Triche serves on the Board of Directors of Novelix Pharmaceuticals, Inc., NanoValent Pharmaceuticals, Inc., GenomeDx, MedGenome, Inc. (f/k/a Silicon Valley Biosystems and Lifecode, Inc.), and Sanguine BioSciences. He was a founding member and director of Avrok Biosciences and its parent company, and Board Chair and CMO of InteroOme, a private entity. | He serves on the boards of several private biotechnology and nanotechnology companies, including MedGenome, Inc. (formerly Silicon Valley Biosystems and Lifecode, Inc.), which are software and technology related. His roles suggest technical expertise likely including programming or related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2004-04-15 | Timothy J. Triche, M.D. has been the Chairman of the Department of Pathology and Laboratory Medicine at Childrens Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. |
| 2005-04-15 | Timothy J. Triche, M.D. has been the Chairman of the Department of Pathology and Laboratory Medicine at Childrens Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. |
| 2006-03-31 | Timothy J. Triche, M.D. has been the Chairman of the Department of Pathology and Laboratory Medicine at Childrens Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. |
| 2007-04-09 | Timothy J. Triche, M.D. has been the Chairman of the Department of Pathology and Laboratory Medicine at Childrens Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private California-based biotechnology company and NanoValent Pharmaceuticals, Inc., a private nanotechnology company. |
| 2008-04-29 | Timothy J. Triche, M.D. has been the Chairman of the Department of Pathology and Laboratory Medicine at Childrens Hospital Los Angeles since 1988. |
| 2009-04-09 | Timothy J. Triche, M.D. has been the Chairman of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. |
| 2010-04-22 | Dr. Triche has been the Chairman of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. |
| 2011-04-29 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children's Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles since 1988. |
| 2012-04-20 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children's Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine. |
| 2013-04-19 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children's Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles since 1988. |
| 2014-04-28 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children's Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles since 1988. |
| 2015-04-24 | He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private biotechnology company, Lifecode, Inc. (f/k/a Silicon Valley Biosystems), a private biotechnology company, and Sanguine BioSciences, a private biomedical research company. |
| 2016-04-26 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private biotechnology company, Lifecode, Inc. (f/k/a Silicon Valley Biosystems), a private biotechnology company, and Sanguine BioSciences, a private biomedical research company. |
| 2017-04-26 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles and serves on boards of private biotechnology and biomedical research companies. |
| 2018-04-24 | Dr. Triche is the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles and serves on the Board of Directors of several private biotechnology and nanotechnology companies, including MedGenome, Inc. (f/k/a Silicon Valley Biosystems and Lifecode, Inc.), which suggests software-related technical expertise. |
| 2019-04-23 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010 and serves on the Board of Directors of several private biotechnology companies. |
| 2020-04-21 | Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010 and serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private biotechnology company, MedGenome, Inc., a private biotechnology company, and Sanguine BioSciences, a private biomedical research company. |
| 2021-04-20 | Dr. Triche is Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles and serves on boards of private biotechnology and nanotechnology companies. |
| 2022-04-19 | Dr. Triche is Director of the Center for Personalized Medicine and serves on boards of private biotechnology and nanotechnology companies, indicating a technical background relevant to software and programming. |
| 2023-04-18 | Dr. Triche serves on the Board of Directors of Novelix Pharmaceuticals, Inc., NanoValent Pharmaceuticals, Inc., GenomeDx, MedGenome, Inc. (f/k/a Silicon Valley Biosystems and Lifecode, Inc.), and Sanguine BioSciences. He was a founding member and director of Avrok Biosciences and its parent company, and Board Chair and CMO of InteroOme, a private entity. |
| 2024-04-16 | Dr. Triche has been director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010, and previously was Chairman of the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles. He also has been a professor of pathology and pediatrics at the University of Southern California Keck School of Medicine in Los Angeles since 1988. |
Data sourced from SEC filings. Last updated: 2025-10-11